Fresenius Group Overview

29.07.2015

DGAP Ad-hoc - Fresenius SE & Co. KGaA: Fresenius raises 2015 earnings guidance

  • Contact

    Markus Georgi

    Senior Vice President Investor Relations
    T: +49 (0) 6172 608-2485
    markus.georgi@fresenius.com

Fresenius SE & Co. KGaA: Fresenius raises 2015 earnings guidance


Fresenius SE & Co. KGaA / Key word(s): Change in Forecast

29.07.2015 22:16

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Fresenius raises 2015 earnings guidance

Based on the excellent financial results in the first half of 2015 and
excellent prospects for the remainder of the year, Fresenius raises its
2015 earnings guidance.

Fresenius now expects net income* growth of 18% to 21% in constant
currency. Previously, the company expected net income* growth of 13% to 16%
in constant currency. The company fully confirms its Group sales guidance.
Sales are now expected to increase by 8% to 10% in constant currency
(previously: 7% to 10%).

Based on the excellent financial results in the first half of 2015 and
excellent prospects for the remainder of the year, particularly in North
America, Fresenius Kabi raises its 2015 guidance.

Fresenius Kabi now expects organic sales growth of 6% to 8%. EBIT growth in
constant currency is expected to be in the range of 18% to 21%. Previously,
Fresenius Kabi projected organic sales growth of 4% to 7% and EBIT growth
in constant currency in the range of 11% to 14%.

* Net income attributable to shareholders of Fresenius SE & Co. KGaA; 2015
before integration costs (~EUR10 million before tax for hospitals acquired
from Rhön-Klinikum AG), before costs for the efficiency program at
Fresenius Kabi (~EUR100 million before tax), and before the disposal gain
from the divestment of two HELIOS hospitals (EUR34 million before tax);
2014 before special items

(Financial statements according to U.S. GAAP)

Fresenius SE & Co. KGaA,
represented by Fresenius Management SE,
Board of Management

Bad Homburg v.d.H., July 29, 2015

End of note


29.07.2015 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------

Language: English
Company: Fresenius SE & Co. KGaA
Else-Kröner-Straße 1
61352 Bad Homburg v.d.H.
Germany
Phone: +49 (0)6172 608-2485
Fax: +49 (0)6172 608-2488
E-mail: ir-fre@fresenius.com
Internet: www.fresenius.com
ISIN: DE0005785604
WKN: 578560
Indices: DAX
Listed: Regulated Market in Dusseldorf, Frankfurt (Prime Standard),
Munich; Regulated Unofficial Market in Berlin, Hamburg,
Hanover, Stuttgart; Terminbörse EUREX

End of Announcement DGAP News-Service

---------------------------------------------------------------------------